A reversible model of acute hepatic failure by temporary hepatic ischemia in the pig

被引:23
作者
Benoist, S
Sarkis, R
Baudrimont, M
Delelo, R
Robert, A
Vaubourdolle, M
Balladur, P
Calmus, Y
Capeau, J
Nordlinger, B
机构
[1] Hop Ambroise Pare, Dept Surg, Serv Chirurg Digest, F-92100 Boulogne, France
[2] Hop St Antoine, INSERM, Res Unit 402, F-75571 Paris, France
[3] Hop St Antoine, Dept Surg, F-75571 Paris, France
[4] Hop St Antoine, Dept Pathol, F-75571 Paris, France
[5] Hop St Antoine, Dept Hematol, F-75571 Paris, France
[6] Hop St Antoine, Dept Biochem, F-75571 Paris, France
[7] Hop Cochin, Cell Biol Lab, F-75674 Paris, France
关键词
hepatic failure; hepatic ischemia; portacaval shunt; experimental surgery; bleeding disorders;
D O I
10.1006/jsre.1999.5778
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. To evaluate new therapies for human fulminant hepatic failure, a suitable large animal model is needed. The purpose of this study was to develop a reversible surgical model of acute hepatic liver failure by transient ischemia in pigs, Materials and methods, Under general anesthesia, an end-to-side portacaval shunt was performed in 17 pigs and tape was laid around the hepatoduodenal ligament. Two days after construction of the functional portacaval shunt, 13 ambulant pigs underwent transient total liver ischemia by tightening of the tape around the hepatoduodenal ligament for 5.5 h, During ischemia, 10% glucose was continuously infused intravenously to prevent hypoglycemia, Results. Ten animals (77%) died with hepatic coma after a mean. duration of 22.5 +/- 1.9 h, The 3 remaining animals survived more than 5 days and were sacrificed. In dying animals, encephalopathy was observed 14 +/- 1.7 h after the onset of ischemia. During ischemia, similar progressive decrease of fibrinogen, platelets, prothrombin time, and factors V and VII activities was observed in dying and surviving animals. Just before death, mean prothrombin and factors V and VII activities were respectively 22 +/- 2, 21 +/- 4,4, and 24 +/- 5%. At 22 h, plasma ammonia and lactate levels were respectively 705 +/- 93 mu mol/L and 10.5 +/- 0.4 mmol/L in dying animals and 249 +/- 75 mu mol/L and 2.9 +/- 0.1 mmol/L in surviving animals (P < 0.01), Estimation of the percentage liver cells necrosed was 74 +/- 4.7% in the survivors and 86 +/- 5.5% in animals who died of hepatic coma (NS), Conclusions, This model is reproducible and reversible and should allow the quantitative evaluation of new technologies, such as bioartificial liver, for the support of hepatic failure in humans, (C) 2000 Academic Press.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 22 条
[1]   FULMINANT AND SUBFULMINANT LIVER-FAILURE - DEFINITIONS AND CAUSES [J].
BERNUAU, J ;
RUEFF, B ;
BENHAMOU, JP .
SEMINARS IN LIVER DISEASE, 1986, 6 (02) :97-106
[2]   ORTHOTOPIC LIVER-TRANSPLANTATION IN FULMINANT AND SUBFULMINANT HEPATITIS - THE PAUL-BROUSSE EXPERIENCE [J].
BISMUTH, H ;
SAMUEL, D ;
CASTAING, D ;
ADAM, R ;
SALIBA, F ;
JOHANN, M ;
AZOULAY, D ;
DUCOT, B ;
CHICHE, L .
ANNALS OF SURGERY, 1995, 222 (02) :109-119
[3]  
ChenardNeu MP, 1996, HEPATOLOGY, V23, P1119
[4]   A REPRODUCIBLE MODEL OF ACUTE HEPATIC-FAILURE BY TRANSIENT ISCHEMIA IN THE PIG [J].
DEGROOT, GH ;
REUVERS, CB ;
SCHALM, SW ;
BOKS, AL ;
TERPSTRA, OT ;
JEEKEL, H ;
TENKATE, FWJ ;
BRUINVELS, J .
JOURNAL OF SURGICAL RESEARCH, 1987, 42 (01) :92-100
[5]   A NEW SURGICAL MODEL OF ACUTE LIVER-FAILURE IN THE PIG - EXPERIMENTAL PROCEDURE AND ANALYSIS OF LIVER-INJURY [J].
FILIPPONI, F ;
FABBRI, LP ;
MARSILI, M ;
FALCINI, F ;
BENASSAI, C ;
NUCERA, M ;
ROMAGNOLI, P .
EUROPEAN SURGICAL RESEARCH, 1991, 23 (01) :58-64
[6]  
FISCHER M, 1976, ACTA HEPATO-GASTRO, V23, P241
[7]   LIVER-TRANSPLANTATION IN PATIENTS WITH FULMINANT HEPATIC-FAILURE [J].
GONZALEZ, EM ;
GARCIA, GI ;
LOINAZ, SC ;
GOMEZ, SR ;
GONZALEZPINTO, I ;
HERNANDEZ, GGD ;
JIMENEZ, RC ;
MAFFETTONE, V ;
PEREZCERDA, F ;
CISNEROS, AC ;
IBANEZ, AJ .
BRITISH JOURNAL OF SURGERY, 1995, 82 (01) :118-121
[8]   HUMAN FETAL HEPATOCYTE TRANSPLANTATION IN PATIENTS WITH FULMINANT HEPATIC-FAILURE [J].
HABIBULLAH, CM ;
SYED, IH ;
QAMAR, A ;
TAHERUZ, Z .
TRANSPLANTATION, 1994, 58 (08) :951-952
[9]  
HICKMAN R, 1974, S AFR MED J, V48, P263
[10]  
HUGUET C, 1972, J CHIR-PARIS, V103, P63